Invasive lobular breast carcinoma (ILC), one of the major breast cancer histological subtypes, exhibits unique clinical and molecular features compared to the other well-studied ductal cancer subtype (IDC). The pathognomonic feature of ILC is loss of E-cadherin, mainly caused by inactivating mutations within the CDH1 gene, but the extent of contribution of this genetic alteration to ILC-specific molecular characteristics remains largely understudied. To profile these features transcriptionally, we conducted single cell RNA sequencing on a panel of IDC and ILC cell lines, as well as an IDC cell line (T47D) with CRISPR-Cas9-mediated knock out (KO) of CDH1. Inspection of intra-cell line heterogeneity illustrated genetically and transcriptionally distinct subpopulations in multiple cell lines and highlighted rare populations of MCF7 cells highly expressing an apoptosis-related signature, positively correlated with a pre-adaptation signature to estrogen deprivation. Investigation of CDH1 KO-induced alterations showed transcriptomic membranous systems remodeling, elevated resemblance to ILCs in regulon activation, and suggests IRF1 as a potential mediator of reduced proliferation and increased cytokine-mediated immune-reactivity in ILCs.
Introduction
Among subtyping systems of breast cancer, histological classification remains an essential criterion due to distinctive features of the major two subtypes-invasive lobular breast carcinoma (ILC) and invasive ductal breast carcinoma (IDC). ILC is the 6 th most common cancer in women, with an estimated 40,000 new cases in 2019, despite accounting for a smaller proportion of breast cancer cases (~15%) compared to IDC (~75%) 1 . ILC shows distinct signaling in pathways essential for breast cancer growth and proliferation compared to IDCsuch as the WNT4 signaling in response to estrogen stimulus or blockade 2,3 , increased PI3K/Akt signaling 4, 5 , enhanced IGF1-IGF1R activation 6 , and dependency on ROS1 7 , which suggest that ILC could benefit from unique treatment strategies. The most distinguishing molecular feature of ILC is loss of E-cadherin, largely arising from inactivating CDH1 mutations. E-cadherin loss disrupts adherens junctions 8 and leads to cells with a smaller and rounder morphology, a more scattered alignment within tumor stroma, and greater metastatic tropisms to ovaries, peritoneum or gastrointestinal (GI) tracts compared to IDC 9 . Such loss often couples with other molecular features, including the aberrant cytosolic localization of p120 10 . Meanwhile, E-cadherin-null tumor models also exhibit certain ILC resemblance: in vivo, the TP53 CDH1 dual KO mouse model showed elevated anoikis resistance and angiogenesis as well as GI tract or peritoneum dissemination similarly to human cases 11 ; while in vitro, hypersensitized PI3K/Akt signaling via GFR-dependent response was identified in both human and mouse ILC cell lines compared to their E-cadherin positive counterparts 4 . Despite numerous clinical observations and biological models, it is currently unclear how E-cadherin loss leads to many of the lobular-specific features.
Intra-tumor heterogeneity (ITH) is a hallmark of treatment resistance and mortality in cancer 12 .
Multiple genetically distinct populations of cancer cells within the same tumor -typically arising from a series of mutational events-are dynamically selected by both intrinsic and external pressures and potentially preserve subclones with high invasiveness and/or drug resistance [13] [14] [15] [16] .
In addition to genetic diversity, transcriptional heterogeneity is also a major driver of ITH in multiple cancer types [17] [18] [19] [20] . Such transcriptional variation, defined as cell states, appear transient and flexible in response to environmental stimuli while partially influenced by DNA alterations.
Although ITH is frequently considered under in-vivo context, previous studies have shown there is considerable heterogeneity even for cell lines grown in culture. However, the extent of this intra-cell line heterogeneity in breast cancer models has not yet been comprehensively characterized 21, 22 .
To quantify ITH between cell lines, referred to as ICH (Inter-Cellular Heterogeneity), and investigate differences between IDC and ILC, we performed single cell RNA sequencing (scRNA-seq) on a panel of eight cell lines. We first investigated ICH in general: most cell lines consist of genetic subclones with unique copy number alterations (CNAs). Transcriptomic heterogeneity was shown for MCF7 cells specifically, revealing that it is dominated by cell cycle, in which cells dynamically transit through several well-defined phases. Despite the majority of cycling cells, a rare population exists distinctively outside the cell cycle with a nontransiting 'dormant' state. Characterization of such 'outliers' uncovered a unique apoptotic signature, which correlates with other functionally related signatures of dormancy in other cell lines and tumors.
We further inspected transcriptomic alterations induced by loss of E-cadherin, using CRISPRmediated CDH1 KO in a commonly used IDC line, T47D. Simple deletion of CDH1 caused cells to cluster independently from wild type (WT) T47D cells in two-dimensional (2D) UMAP embedding. Given such distinctive and systemic differences are likely mediated by transcriptional factors (TFs) 23 , we deduced regulon activation states from scRNA-seq data, which illustrated elevated resemblance towards two out of the three ILCs in CDH1 KO versus WT cells. Among the TFs identified, we found a regulon of IRF1 activated by CDH1 KO, which also show higher expression in luminal A ILC tumors than IDCs. While the mechanism whereby loss of E-cadherin activates IRF1 is not known, IRF1 regulon activation conforms to the lessproliferative, and potentially more immune-enriched 24 features of the lobular subtype.
Results

scRNA-seq of breast cancer cell lines
To investigate the effect of loss of E-cadherin in ILC, we generated T47D cells with CDH1 KO using CRISPR-Cas9, and ensured its depletion at the protein level. scRNA-seq was performed on this T47D KO strain and its parental WT strain, along with seven additional groups of cells: the IDC cell line MCF7, MCF7 with ESR1 Y537S mutation, referred to as MCF7-mut; three ILC cell lines: MDA-MB-134-VI, SUM44-PE, BCK4; as well as two immortalized but noncancerous cell lines: the breast MCF10A, and human embryonic kidney 293 (HEK293) cells.
Each cell line was cultured separately in standardized conditions, mixed at similar number for standard 10X chemistry v3 library preparation, and sequenced with NovaSeq 6000 system ( Fig.   1a ).
Dimensional reduction in 2D UMAP revealed eight distinct clusters ( Fig. 1b) . We deconvoluted single cell identities by mapping transcriptomes of each cluster to six cell lines with available bulk-RNA reference. Except for cluster 2, every cluster showed distinctive similarity to a specific bulk transcriptome, and thus identity was confidently assigned (Supplementary Figure   1 ). Cluster 2 was by default assigned as BCK4, which has no bulk RNA-seq data, and this identity was further confirmed by the exclusively high mucin expression in this cell line ( Supplementary Figure 1 ). T47D CDH1 KO and WT cells were two proximal but discrete clusters and showed altered E-cadherin expression as expected ( Supplementary Figure 1) . In contrast, the MCF7-mut and WT cells, despite being equally mixed, did not cluster separately, indicating limited transcriptomic differences when grown in standard media without estrogen deprivation. As these cells couldn't be separated, we refer to them hereafter as MCF7 cells. After data pre-processing, the final single cell library consisted of 4,614 cells, approximately 500 cells for each cluster except MCF7 and HEK293, both of which contain approximately 900 cells ( Fig.   1b ). Expression of key breast cancer genes were examined ( Supplementary Figure 1) , including hormone receptors (ESR1 for estrogen receptor, PGR for progesterone receptor, ERBB2 for human epidermal growth factor receptor 2), histology marker (CDH1 for E-cadherin) and proliferation indicator (MKI67 for Ki67). Consistent with the previous characterizations [25] [26] [27] , ESR1 was expressed higher in the six breast cancer cell lines compared to MCF10A or HEK293;
PGR showed high expression in T47D and BCK4 cells and low to medium in others; and ERBB2 expression was higher in BCK4 than other cell lines. Consistent with histological classification, CDH1 was highly expressed in IDC cell lines (MCF7, T47D WT) and MCF10A, compared to ILC cell lines or HEK293. All cell lines had abundant expression of MKI67.
Despite cell-line specific expression, all markers showed a large variation in RNA abundance.
Such heterogeneity is also reflected in PAM50 subtypes, calculated for each single cell with the subgroup-specific gene-centering method 28 (Fig. 1f ) -each cell line exhibits several PAM50 calls in spite of the luminal subtype dominance.
To quantify inter and intra-cell line differences, we calculated Euclidean distance among all pairs of single cells (Fig. 1d ). Cells from each cell line showed greater similarity to each other, and T47D WT and KO were highly similar to each other. This analysis highlighted the intrinsic intercell line distinctions. Intra-cell line distances were also selected and compared, revealing intracell line heterogeneity which was highest in MCF10A, relatively consistently among breast cancer cells, and lowest in HEK293 ( Fig. 1e ).
Inferred copy number aberrations (CNAs) reveal intra-cell line subpopulations that in part account for transcriptional heterogeneity
Cell lines are the most widely used laboratory model of cancer. However, studies have shown dissimilarities among breast cancer cell lines from different laboratories, potentially as a result of different culture conditions and/or intrinsic evolution of cells with genomic instability 21 . Even within a single cell line, transcriptomic subpopulations exist -composing a small or median proportion of the whole population, and are only partially explained by CNA 22 .
We examined genetic heterogeneity in cell lines using CNA inferred from scRNA-seq, a method described in multiple previous studies 18, 29 . To test robustness and accuracy of this method, we incorporated two external 10X scRNA-seq datasets, which investigated the same cell lines (MCF7 and T47D cells cultured in standard media 29 , plus three different MCF7 strains 21 ). Different strains of the same cell type exhibited high resemblance to each other, as shown by coclustering of T47D CDH1 WT and KO cells with the external T47D dataset ( Fig. 2a ). Similarly, our MCF7 cells clustered with MCF7 strains from two other studies, in a different hierarchical branching to T47Ds. Three ILC cell lines (MDA-MB-134-VI, BCK4 and SUM44-PE) clustered together in a third independent branch from the hierarchical tree.
To characterize genetic ICH, we identified subpopulations from CNA using selected chromosome arms as described by Kinker et al. 22 (Fig. 2b ,c; Supplementary Figure 2 ). For cell lines exhibiting CNA subclones, we compared the genetic subclones with transcriptomic subclones (derived from Louvain clustering from normalized RNA expression, and annotated by phases deduced from cell cycle gene expression) ( Fig. 2d ). Most of the cell lines investigated (5 out of 8) showed distinct genetic subpopulations not attributed to the cell cycle or scRNA-seq library quality ( Fig. 2d, Supplementary Figure 2 ). Some but not all CNA clusters (CNA cluster 1 in MCF7, CNA cluster 3 in T47D WT and MCF10A), taking up a minority of the total population, corresponded to a transcriptomic subcluster based on both 2D layout and Louvain clustering ( Fig. 2d ).
Apoptotic signature derived from a dormant-like MCF7 subpopulation
To investigate transcriptomic ICH, we focused on MCF7 cells, which had sufficient cell numbers in favor of statistical analysis. To cluster cells and select indicative features simultaneously, we used non-negative matrix factorization (NMF), which generated a matrix highlighting three major blocks of cells with corresponding genes, referred to as NMF clusters/genes ( Fig. 3a , Supplementary Table 2 ).
Most cells belonged to NMF cluster 1 or 3, which overlapped with the two major RNA clusters (Fig. 3c ), and the transition through different states predicted by RNA velocity analysis ( Fig. 3d ).
Despite the majority of cells apparently transiting through the cell cycle, there existed a minor population (NMF cluster 2) exhibiting a 'dormant-like' non-transiting state. This is consistently indicated by high latent time values from RNA velocity analysis ( Fig. 3e ). An inspection of highly expressed genes in this cluster revealed an enrichment of apoptosis-related pathways. We thus refer to this cluster of cells as Apop cells and their corresponding genes as ApopSig (signature). Interestingly, a recent report revealed that MCF7 cells contain a rare 'pre-adapted endocrine resistant' sub-population even when grown in regular media (DMEM, 10% fetal calf serum) 29 . A pre-adaptation signature (highly-expressed PA Up genes or lowly-expressed PA Down genes), derived from these cells, revealed a negative correlation with cell cycle and was indicative of dormancy. It is hypothesized that these pre-adapted cells may evade growth inhibition by anti-estrogens via exhibiting the less-aggressive dormant-like features. Motivated by this discovery, we investigated the association of the ApopSig with the pre-adapted signature. Despite a limited overlap in genes present in these two signatures ( Supplementary Figure 3 Supplementary Figure 3 ). ApopSig showed enrichment in Luminal A tumors, which has the best prognosis among all PAM50 subtypes ( Fig. 3i ). High expression of ApopSig also indicates good prognosis, possibly due to its less aggressive manifestations, which holds true even when restricted to the estrogen receptor positive and LumA cohort (HR = 0.18, p = 0.022 by log rank test) ( Supplementary Figure 3 ).
CDH1 point mutation results in loss of spliced E-cadherin RNA and alters expression programs related to the ILC phenotype
CRISPR-Cas9-mediated CDH1 KO is induced by a single base pair deletion, which generated a premature stop codon, mimicking missense mutaitons found in ILC tumors and in genetically characterized ILC cell lines 30 . This point mutation led to depletion of both E-cadherin RNA and protein ( Fig. 4a , Supplementary Figure 4 ), caused cells to lose cell-cell adhesion ( Fig. 4a ) and induced a profound effect on the transcriptome landscape, illustrated by distinct clustering of Figure 4 ). When specifically examining spliced versus unspliced E-cadherin RNA abundance, the three ILC cell lines and T47D CDH1 KO showed depleted spliced RNA abundance but comparable unspliced RNA distribution compared to MCF7 and T47D WT cells ( Supplementary Figure 4 ). This suggests that CDH1 mutation does not affect the nascent RNA transcript but post-transcriptional events, e.g., causing insufficient splicing or rapid degradation 31 . This result was mirrored in human tumors from TCGA 32 , in which IDC vs ILC showed a difference in exon RNA sequeuncing coverage than intron regions of CDH1 ( Supplementary Figure 4) .
CDH1 KO and WT cells (Supplementary
We explored what genes and pathways were differentially expressed (DE) after CDH1 KO. As expected, cell junction-related components were down-regulated following loss of E-cadherin, along with some less specific pathways such as developmental or cytosolic processes ( Fig. 4c ). This is consistent with morphology changes in CDH1 KO cells, which were more round with brighter margins, indicating decreased cell-cell contacts (Fig. 4a ). Components in membranous system, endomembrane in particular, as well as stress response-related genes, were up-regulated in CDH1 KO cells ( Fig. 4c ). Interestingly, extracellular vesicle-related pathways were enriched in both up and down regulated genes ( Fig. 4c ).
To investigate whether the transcriptomic changes in CDH1 KO cells versus WT truly reflect ILC-IDC differences in tumors, we analyzed the expression of DE programs, refined by the overlap of DE genes with the original GO program ( Supplementary Table 3 ), among the IDC and ILC in TCGA LumA cases. The majority of down-regulated gene sets (10 out of the 16 deduplicated gene sets) and some up-regulated ones (2 out of the 13 deduplicated gene sets) showed significant differences between ILC and IDC tumors, consistent with the trend in CDH1 KO and WT models ( Fig. 4d ).
An IRF1 regulon is activated following loss of E-cadherin, and is elevated in ILC
Loss of E-cadherin in epithelial cells has been reported to induce expression of multiple transcript factors (TFs) and trigger profound downstream phenotypic changes, such as metastasis promotion through epithelial-mesenchymal transition (EMT) 33 . While EMT does not seem to be a classical feature of ILCs 34, 35 , the vast transcriptomic changes in CDH1 KO cells strongly suggest involvement of downstream TFs. We therefore searched for TF regulatory modules (regulons) which are increased or decreased in activity following CDH1 deletion in T47D cells and investigated their expressions in ILC vs IDC tumors. Regulon activation profiles in each cell line was calculated using pySCENIC 36 . Commonly deduced regulons were binarized with an optimized threshold on AUC distribution and merged for all cell lines, which were used for hierarchical clustering (Fig. 5a ,b, Supplementary Table 4 ). To more specifically quantify inter-cell line regulon activation differences, we measured the Jaccard Index between individual cells ( Fig. 5c ), where larger value indicates higher resemblance. Notably, T47D CDH1 KO cells showed higher similarity to two out of three ILC cells (MDA-MB-134-VI, BCK4) than the two IDC cell lines (MCF7, T47D WT), (Fig. 5c , FDRs < 0.01 based on two sample K-S test, BH adjustment). This observation further supported that CDH1 KO in IDC cells initiates an ILC specific TF regulon activation.
We next identified regulons specifically activated following CDH1 KO. Fourteen TFs were identified in this manner, which were further investigated regarding expression differences in LumA IDC and ILC in TCGA. Only IRF1 and CTCF showed significant differences (FDR<0.05), and only IRF1 exhibits higher expression in ILC (Supplementary Figure 5 ). Intriguingly, IRF1 expression was also negatively correlated with CDH1 in tumors ( Fig. 5d ), which further supports its activation in a lobular specific and E-cadherin associated manner.
Similar observations were obtained in cell lines where ILCs generally have lower CDH1 and higher IRF1 or IRF1 regulon activation levels while IDCs show the opposite (except IRF1 regulon score of SUM44-PE, which is potentially due to influence of small sample size input to algorithm performance) (Supplementary Figure 5 ).
IRF1 is a canonical target of IFNγ, and in a pathway known to affect cell survival and proliferation. We next therefore examined co-expression of IRF1 regulon activation with Most pathways (4 out of 6) which were positively correlated showed enriched expression in ILC Discussion scRNA-seq allows for single cell resolution of the transcriptome and is fundamentally altering our understanding of normal development and cancer. In this report, we used scRNA-seq to investigate inter-cellular heterogeneity of breast cancer cell lines, and specifically the unique features of ILC. scRNA-seq readily discerned differences between the cell lines, and genetic subclones were identified in most cell lines. Transcriptomic changes faithfully predicted the transition of cells through the cell cycle. However, in MCF7, a minor subpopulation of cells exist outside of the cell cycle, and these cells showed a dormancy related phenotype previously reported by other group 29 . ILC cell lines were distinct from IDC cell lines, and genetic deletion of CDH1 caused transcriptional modeling in T47D as to be more similar to ILC than IDC cell lines. An investigation of activated regulons following loss of CDH1 identified IRF1, which was also activated in LumA ILC.
scRNA-seq of cell lines revealed genetic and transcriptomic subpopulations within cell lines. A previous report of scRNA-seq in cell lines identified genetic and transcriptomic subpopulations in many cell lines, but not MCF7 22 . This inconsistency is unlikely due to strain artefacts, as our cell lines clustered correctly using CNA with the same cell lines from two other independent datasets, including the dataset which didn't identify subclones in MCF7 22 . A possible reason is that we sequenced around five times the number of cells and thus had more power to find subpopulations. We found that MCF7 cells contained a subpopulation of non-cycling cells (Apop cells) with a dormancy phenotype reported by others 29 . Importantly, Apop cells corresponded to a subpopulation with pre-adaptation (PA) to endocrine therapy -also identified through scRNAseq. The PA signatures are reported to support cancer survival in acute hormone deprivation.
This strengthens the concept of transcriptionally-distinct minor subpopulations, which are present at all times, but in case of a harsh environment (e.g. hormone starvation), use their dormant phenotypes to survive and ultimately cause endocrine resistance.
scRNA-seq showed that IDC and ILC cell lines have distinct transcriptional programs, similar to tumors in TCGA; and that genetic loss of CDH1 in an IDC cell line causes extensive transcriptional remodeling to make the resultant IDC CDH1 KO cell line to resemble ILC, in both morphology and pathways. E-cadherin deficiency in lobular breast cancer was shown to be functionally associated with other structural proteins, e.g., elevated reliance on p120 in cytokinesis regulation 7 . From our data, we also observed structure-related transcriptomic changes after CDH1 KO, such as junctional disruption; along with other features as expression increasement in endomembrane system, stress response and certain exocytosis pathways. These phenotypes from cell models were similarly identified when comparing clinical IDC and ILC LumA tumors.
The depletion of E-cadherin RNA and protein has been recognized in the majority of ILC tumors while promoter methylation is not associated with histological types 37 . This on one hand, justifies our use of cell lines for modeling ILC tumors, where MDA-MB-134-VI, SUM44-PE and T47D all harbor little methylation at CDH1 promoter region (BCK4 had not been investigated) 38 ; and on the other hand, suggests post-transcriptional modifications as potential driver of E-cadherin depletion. Our observation of alterations in CDH1 spliced RNA, but not unspliced RNA in ILC from scRNA-seq data, provides evidence supporting this hypothesis. This was validated in TCGA bulk RNA-seq data via an approximation method of split exon/intron quantification, where we show more comparable intron RNA coverage in ILC as in IDC than exons. Notably, CDH1 in T47D KO and ILCs all bear a pre-mature termination codon (PTC) while not necessarily contain disruptive mutations at splicing site (BCK4 mutation is currently unknown). In this context, loss of spliced mRNA is likely to result from the PTC-induced nonsense mediated decay, the main driver of E-cadherin transcript depletion as described in PTCbearing gastric cancers 39 .
While E-cadherin is a membrane protein, its loss causes distinct transcriptional reprogramming, likely an indirect effect on TF activity, for example through inhibiting Kaiso's TF activity as shown in mouse models 23 . To investigate this further, we examined regulon activation and identified an IRF1 regulon as being activated following CDH1 KO, meanwhile showing higher RNA expression in ILC cell lines or tumors. As a tumor suppressor, IRF1 inhibits proliferation and prompts cell death. In breast cancer, IRF1 depletion could well indicate endocrine resistance, while its induction by IFNg sensitize cancer cells to endocrine therapy 40 . These traits conform to multiple ILC phenotypes compared to IDC, e.g., being less proliferative and more apoptotic 41,42 ; and showing a better response to as well as a better outcome upon adjuvant endocrine therapy 43, 44 . Specifically, IRF1 mediates antiestrogen-induced apoptosis, by increasing expression of pro-apoptotic genes (BAK, BAX, BIK) while reducing that of anti-apoptotic genes (BCL2, BCLW, survivin) 45 . This corresponds to our observation of positive correlation of IRF1 regulon with hallmark apoptotic or p53 pathways, and the preferential activation of both pathways in ILC than IDC among LumA tumors. Apart from IFNg, IRF1 can also be induced by other factors, such as IL-6, tumor necrosis factor (TNF) α and TGFβ 40, 46, 47 . Consistently, these pathways also correlate with IRF1 regulon through GSVA analysis ( Fig. 5g , Supplementary   Figure 5 ) while most of them showed enhanced signaling in ILCs (Fig. 5f ), e.g., TNFa and IL-6 pathways. While pro-inflammatory signalings in tumor microenvironment has a complicated role in prognosis due to the pleiotropy of cytokines, they could reflect a coordination of enriched 18 immune infiltration and/or enhanced immune reactivity in ILC tumors. Such immune signature enrichment, as has been shown previouslys 24 Microscope.
Cell line preparation
MCF7, T47D, MDA-MB-134-VI, SUM44-PE, MCF10A and HEK293 were all purchased from American Type Culture Collection (ATCC) and identity authenticated by DNA fingerprinting (University of Arizona). Cells were routinely tested for mycoplasma and were negative at all times. MCF7 with ESR1-Y537S were generated previously 50 . BCK4 was a gift from Brita Jacobson (University of Colorado). Cells were maintained in media described in Supplementary   Table 1 .
Single-cell RNA sequencing
Nine groups of cells, each with viability > 90% based upon Trypan Blue staining and Invitrogen automated cell counting, were fixed separately at equal number (round 1,000,000 cells per group) in 90% methanol at 4°C for 15 minutes and temporarily stored at -80°C. The cell suspension was rehydrated, mixed and processed following 10X Genomics 3' Chromium v3.0 protocol at University of Pittsburgh Genomics Core. The library was sequenced with NovaSeq 6000 S1 flow cell at the UPMC Genome Center, getting around 400 million paired reads in total. For the five breast cell lines, FASTQ files were obtained from Sequence Read Archive (SRP186687, SRP026537, SRP064259), quantified using Salmon (v0.12.0) 59 using GRCh38 reference. For HEK293, RNA counts from GSM1867011 and GSM1867012 were directly downloaded and the average expression for all genes of these two sample were used subsequently. 1,444 genes were present in all the three data sources (breast cell lines, HEK293 as reference cell lines; and scRNA-seq (3,000 genes by 4,614 cells) as query cells), which were selected for further analysis.
scRNA-seq data pre-processing
Pearson correlation was calculated between each single cell in the 8 clusters and each reference cell line using log normalized counts. The reference with the most significantly right-skewed coefficient distribution was assigned to the query cluster ( Supplementary Figure 1) . Every cluster was successfully assigned except cluster 2, which was by default BCK4. This was further confirmed by the high levels of MUC2 expression ( Supplementary Figure 1 ). WT and KO T47D cells were distinguished by CDH1 expression ( Supplementary Figure 1 ).
PAM50 assignment
The six breast cancer cell lines (cell lines except MCF10A and HEK293) were classified with PAM50 subtypes with subgroup-specific gene-centering method 28 , using either tumor or cell line as reference. Normalized expression of genes in scRNA-seq data that overlapped with the PAM50 panel were selected and centered with the pre-calculated ER+ group-specific quantiles, as described by Zhao et al. 28 For each single cell, a Spearman's rank correlation coefficient was calculated between the centered expression vector and four PAM50 subtype (LumA, LumB, HER2, Basal) centroids, using either tumor data from the original University of Northern Carolina dataset, or bulk RNA-seq of representative cell lines generated as described above Roden et al. 60 ). These correlation coefficients were standardized in each cell using z-score, and the subtype with highest correlation coefficient was assigned to this cell, which showed
LumA/LumB dominance (Fig. 1f ).
CNA Inference
Two external datasets with scRNA-seq data of cell lines were integrated with our in-house data for CNA inference -MCF7 and T47D cells from Hong et al. 29 , and three MCF7 strains (WT-3,4,5) from Ben-David et al. 21 A raw count matrix from Hong et al. 29 was directly downloaded from GSE122743 while FASTQ files from Ben-David et al. 21 were reprocessed to derive the count matrix, following steps described in the scRNA-seq data pre-processing section. The average expression vector of the in-house MCF10A cells was utilized as reference.
Expression count matrix of each cell strain was first log normalized, sorted by genes' chromosomal coordinates, and then merged with others using commonly detected genes. 300 cells were randomly selected from each strain. Only chromosome arms containing more than 100 genes were kept, and single cell expression was averaged with a moving 100 gene window. This averaged expression was used to fit a linear regression model against the MCF10A reference vector, and the residual value was assigned as the inferred CNA ( Fig. 2a ).
Identify cell subclusters from inferred CNA
To identify intra-cell line CNA subclusters we adopted a similar method as reported by Kinker et al. 22 For each cell line, the log normalized expression matrix was centered for each gene and moving average of 100 gene window was calculated along the genome. For each chromosome arm, a gaussian mixture model (GMM, implemented in scikit-learn 61 ) was fitted to the distribution. Selected chromosome arms should best fit with more than one component in GMM, each of which having more than 20 cells with confidence higher than 95%. These selected chromosome arms were then used for hierarchical clustering to identify subcluster of cells (Euclidean distance, Ward method) (Fig. 2c) . The top three hierarchical branching were extracted and differentially colored as the potential CNA subpopulation.
Identify cell subclusters from RNA
To identify intra-cell line transcriptomic subpopulations, RNA counts of each cell line were extracted from raw data, filtered, log normalized and imputed, using the top 5000 variable genes following steps described in the scRNA-seq data pre-processing section. Cells were laid out in a force-directed graph drawing implemented in Scanpy 53 . Louvain clustering was conducted in each cell line with resolution=1 in Fig. 2d as an empirical value; and with resolution = 0.4 for MCF7 in Fig. 3a , as to generate 3 clusters in correspondence to the 3 clusters via other classification methods.
Cell cycle scoring
Five lists of phase marker genes (M/G1, G1/S, S, G2, G2/M) of the cell cycle were obtained 62 .
Log normalized expression of each cell line was acquired as described in the last section. For each cell line and phase, correlation coefficients were calculated between each gene and the average gene set expression. Genes with the highest (the upper 40% quantile) coefficients were selected as the refined cell cycle markers for that cell line. A score for each phase was calculated for each cell, as the average expression of cell cycle markers minus that of a randomly selected gene set of the same size (implemented in Scanpy 53 ), which is standardized firstly in each cell then in each phase by z-score (Fig. 3c ). The phase with the highest score was assigned to the cell.
RNA velocity analysis
For each cell line, the union of the refined cell cycle markers were selected to illustrate cell state transitioning dynamics, following the RNA velocity pipeline implemented in scVelo 52 using stochastic mode, with latent time calculated under the same setting. Stream arrows indicating transition dynamics were depicted on the force-directed graph drawing of individual cell line.
NMF clustering
NMF was performed as described by Puram, et al. 18 in MCF7 cells. The log normalized expression matrix of 5000 genes and 977 cells was centered for each gene to obtain the relative expression ( *,+ ) for every gene i in each single cell j. Negative values was replaced by 0 and NMF was then conducted with k ranging from 5 to 15 (implemented in sklearn.decomposition.NMF). For each k, top 50 genes with highest D score 63 were defined as a gene set. Recurrent gene sets, which have Jaccard Index > 0.6 with at least one another gene set, were selected and merged as indicative features (101 genes). *,+ of these 101 genes among MCF7 cells were standardized for each cell by cell-wise z-score and showed in heatmap, clustered for both genes and cells (Euclidean distance, Ward method) ( Fig. 3a) . Clades from the top three hierarchical branching were selected as NMF clusters.
Differentially expressed genes
Differentially expressed genes (DEGs) for each cell line were derived by comparing this cell line versus all other cells using Wilcoxon test (BH adjustment, implemented in Scanpy 53 ) (Fig. 1c ).
To calculate DEGs in T47D CDH1 KO versus WT cells, the two groups were extracted from raw data, filtered, log normalized and imputed, using the top 3000 variable genes following steps described in the scRNA-seq data pre-processing section. DEGs were calculated comparing between each other (Wilcoxon test, BH adjustment). The top 100 genes with the smallest FDR were selected as marker genes for each group.
Gene set enrichment analysis
Gene lists of interest (marker genes of MCF7 NMF clusters in Fig. 3 ; T47D WT and KO DEGs in Fig. 4 ) were submitted to the gProfiler website 64 
Public gene sets
Gene sets used for GSVA scoring were obtained as follows: ApopSig derives from genes corresponding to NMF cluster 2 (Fig. 3a) ; PA SWNE Up or Down signatures, representing preadaption features, were accessed from Hong et al. 29 ; hallmark gene sets in Fig. 5g were from MSigDB hallmark dataset 66 ; and other intrinsic tumor signatures in Fig. 3h were from Puram et al. 18 Refined GO terms in Fig. 4d are the overlap of the original GO term with DEGs between T47D WT and KO cells. Target genes in IRF1 regulon from ChEA or ENCODE datasets were downloaded from Enrichr libraries 67, 68 (ChEA_2016, ENCODE_TF_ChIP-seq_2015).
GSVA scoring in TCGA and METABRIC
Expression count matrix of TCGA breast cancer dataset was obtained from cBioportal 69, 70 (meta_RNA_Seq_v2_expression_median.txt) and log normalized as E %,' = log 1 2 3,4 ∑ 2 3,4 4 for sample i and gene j; corresponding breast cancer subtypes (PAM50, histology) were obtained from Ciriello et al. 37 METABRIC 71 RNA microarray data was downloaded from Synapse and log normalized. Gene set variation analysis (GSVA) of selected gene set was performed with GSVA R package 48, 49 , in ssgsea or gsva mode with default parameters. Comparisons between TCGA ILC versus IDC cases are all limited to LumA population unless otherwise specified.
For survival analysis, only estrogen receptor positive (ER+) and LumA patients were selected to avoid influence caused alone by PAM50 subtype. ApopSig ssGSEA scores were stratified into low and high levels with optimized threshold using in surv_cutpoint and surv_categorize implemented in R survminer package (https://cran.rproject.org/web/packages/survminer/index.html). Kaplan-Meier curve were plotted for each group using disease free survival, with p value from log-rank test, and hazard ratio (HR) calculated using univariate Cox regression (coxph in R survival package, https://cran.rproject.org/web/packages/survival/index.html).
CDH1 exon and intron coverage
TCGA RNA BAM files were accessed from The Pittsburgh Genome Resource Repository (https://www.pgrr.pitt.edu/). Bulk RNA-seq BAM files of breast cancer cell lines were generated as described in Tasdemir et al. 72 RNA counts of each exon and intron of CDH1 was quantified with bedtools (v2.29.1) counts mode and normalized by dividing the total number of counts within the sample ( Supplementary Figure 4) . One representative ILC and IDC patient from TCGA 37 , along with one cell sample from each cell line, were selected for visualization using Integrative Genome Viewer 73 , showing CDH1 coverage from intron 11 to exon16 with GRCh38 as reference genome ( Supplementary Figure 4) .
Regulon activation profiles
Regulon activities were inferred from raw expression counts of each cell line following the default pySCENIC 36 pipeline (https://github.com/aertslab/pySCENIC). Each cell was eventually assigned with an AUC score for every regulon, indicating its activation status. These scores were then binarized into either "on" or "off" states, by setting an optimized threshold on the distribution of each regulon among all cells using the skimage.filters.threshold_minimum function. Target genes of each regulon were selected if it is commonly deduced under that TF in at least two of the following cell lines: T47D KO, MDA-MB-134-VI, SUM44-PE and BCK4
( Supplementary Table 4 ).
Jaccard index
For every pair of cells, a Jaccard index was calculated using the two corresponding binarized regulon activation vector of the two cells, X and Y, as ( , ) = ;∩= ;∪ = , a large value of which indicates higher similarity. For every two cell lines, the Jaccard index of all pairwise combinations between the two population was selected and plotted as the cumulative distribution ( Fig. 5c ).
Statistical analyses
All the analyses and plots were generated in Python (v3.7) (http://www.python.org) or R (v3.6) (www.r-project.org). All statistical tests are two-sided, unless specified otherwise.
Code availability
Codes and important intermediate data will be available on github (https://github.com/leeoesterreich?tab=repositories) upon publication.
Data availability
Processed files are deposited in Gene Expression Omnibus (GSE144320) and raw FASTQ files are deposited at SRP245420, which will be available upon publication. Processed data can also be accessed interactively through our server, implemented by SCelVis 74 , at http://167.172.151.214:8050/dash/viz/CellLines.
